322 related articles for article (PubMed ID: 27384265)
21. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease.
Melov SJ; Shetty PS; Pasupathy D; Kirby A; Sholler GF; Winlaw DS; Alahakoon TI
Prenat Diagn; 2021 Jan; 41(1):35-42. PubMed ID: 33067884
[TBL] [Abstract][Full Text] [Related]
22. Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.
Prescrire Int; 2016 Apr; 25(170):96-9. PubMed ID: 27186622
[TBL] [Abstract][Full Text] [Related]
23. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
Bellantuono C; Vargas M; Mandarelli G; Nardi B; Martini MG
Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291
[TBL] [Abstract][Full Text] [Related]
24. In utero exposure to ultrafine particles promotes placental stress-induced programming of renin-angiotensin system-related elements in the offspring results in altered blood pressure in adult mice.
Morales-Rubio RA; Alvarado-Cruz I; Manzano-León N; Andrade-Oliva MD; Uribe-Ramirez M; Quintanilla-Vega B; Osornio-Vargas Á; De Vizcaya-Ruiz A
Part Fibre Toxicol; 2019 Jan; 16(1):7. PubMed ID: 30691489
[TBL] [Abstract][Full Text] [Related]
25. Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta.
Xu Y; Agrawal S; Cook TJ; Knipp GT
Placenta; 2008 Nov; 29(11):962-9. PubMed ID: 18829104
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study.
Richardson JL; Martin F; Dunstan H; Greenall A; Stephens S; Yates LM; Thomas SHL
Reprod Toxicol; 2019 Mar; 84():108-113. PubMed ID: 30639403
[TBL] [Abstract][Full Text] [Related]
27. Maternal administration of the herbal medicine toki-shakuyaku-san promotes fetal growth and placental gene expression in normal mice.
Li H; Wada E; Wada K
Am J Chin Med; 2013; 41(3):515-29. PubMed ID: 23711139
[TBL] [Abstract][Full Text] [Related]
28. Trichloroethylene, trichloroacetic acid, and dichloroacetic acid: do they affect fetal rat heart development?
Fisher JW; Channel SR; Eggers JS; Johnson PD; MacMahon KL; Goodyear CD; Sudberry GL; Warren DA; Latendresse JR; Graeter LJ
Int J Toxicol; 2001; 20(5):257-67. PubMed ID: 11766123
[TBL] [Abstract][Full Text] [Related]
29. Fetal and placental development in early gestation of hyper-prolific sows.
Lyderik KK; Østrup E; Bruun TS; Amdi C; Strathe AV
Theriogenology; 2023 Feb; 197():259-266. PubMed ID: 36527862
[TBL] [Abstract][Full Text] [Related]
30. Apathy symptoms induced by low-dose venlafaxine: Two cases.
Sato S; Sodeyama N; Matsuzaki A; Shiratori Y
Neuropsychopharmacol Rep; 2020 Jun; 40(2):196-197. PubMed ID: 32267090
[TBL] [Abstract][Full Text] [Related]
31. Venlafaxine-induced damage to seminiferous epithelium, spermiation, and sperm parameters in rats: A correlation with high estrogen levels.
de Santi F; Beltrame FL; Rodrigues BM; Junior MJVP; Scaramele NF; Lopes FL; Cerri PS; Sasso-Cerri E
Andrology; 2021 Jan; 9(1):297-311. PubMed ID: 32598512
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of heart malformations in B6C3F1 mouse fetuses induced by in utero exposure to methyl chloride.
Wolkowski-Tyl R; Lawton AD; Phelps M; Hamm TE
Teratology; 1983 Apr; 27(2):197-206. PubMed ID: 6867941
[TBL] [Abstract][Full Text] [Related]
33. Effects of hydralazine on pregnant rats and their fetuses.
Pryde PG; Abel EL; Hannigan J; Evans MI; Cotton DB
Am J Obstet Gynecol; 1993 Oct; 169(4):1027-31. PubMed ID: 8238114
[TBL] [Abstract][Full Text] [Related]
34. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
Leandro SM; Furukawa LN; Shimizu MH; Casarini DE; Seguro AC; Patriarca G; Coelho MS; Dolnikoff MS; Heimann JC
Physiol Behav; 2008 Sep; 95(1-2):145-51. PubMed ID: 18572207
[TBL] [Abstract][Full Text] [Related]
35. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
[TBL] [Abstract][Full Text] [Related]
36. Maternal choline supplementation in a rat model of periconceptional alcohol exposure: Impacts on the fetus and placenta.
Steane SE; Fielding AM; Kent NL; Andersen I; Browne DJ; Tejo EN; Gårdebjer EM; Kalisch-Smith JI; Sullivan MA; Moritz KM; Akison LK
Alcohol Clin Exp Res; 2021 Oct; 45(10):2130-2146. PubMed ID: 34342027
[TBL] [Abstract][Full Text] [Related]
37. Prenatal zinc deficiency: influence on heart morphology and distribution of key heart proteins in a rat model.
Lopez V; Keen CL; Lanoue L
Biol Trace Elem Res; 2008 Jun; 122(3):238-55. PubMed ID: 18224284
[TBL] [Abstract][Full Text] [Related]
38. Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain.
Goeden N; Velasquez J; Arnold KA; Chan Y; Lund BT; Anderson GM; Bonnin A
J Neurosci; 2016 Jun; 36(22):6041-9. PubMed ID: 27251625
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive high-resolution ultrasound reveals structural and functional deficits in dimethadione-exposed fetal rat hearts in utero.
Purssell E; Weston AD; Thomson JJ; Swanson TA; Brown NA; Ozolinš TR
Birth Defects Res B Dev Reprod Toxicol; 2012 Feb; 95(1):35-46. PubMed ID: 22127902
[TBL] [Abstract][Full Text] [Related]
40. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
Islin J; Munkboel CH; Styrishave B
Toxicol In Vitro; 2018 Mar; 47():63-71. PubMed ID: 29100959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
